Brief: Pharnext: Successful Intermediate Analyses For Pleo-Cmt Phase III Clinical Trial

Pharnext SCA

29/11/2017 17:30

Nov 29 (Reuters) - PHARNEXT SAS  PHARN.PA : 
    * SUCCESSFUL INTERMEDIATE ANALYSES FOR PLEO-CMT PHASE III 
CLINICAL TRIAL IN CHARCOT-MARIE-TOOTH DISEASE TYPE 1A 
    * PLEO-CMT STUDY TO CONTINUE AS PLANNED WITHOUT INCREASING 
NUMBER 
OF PATIENTS 
    * ANALYSUS ALLOW CO TO CONFIRM SCHEDULE FOR FINAL RESULTS BY 
SECOND HALF OF 2018 
 
Source text for Eikon:  ID:nEQbyzs64a  
Further company coverage:  PHARN.PA  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))